Patents Represented by Attorney Genencor International, Inc.
  • Patent number: 6602841
    Abstract: A granule having high stability and low dust is described. The granule includes a hydrated barrier material having moderate or high water activity. Also described are methods of producing the granules.
    Type: Grant
    Filed: June 16, 2000
    Date of Patent: August 5, 2003
    Assignee: Genencor International, Inc.
    Inventors: Nathaniel T. Becker, Robert I. Christensen, Jr., Alfred L. Gaertner, Mahmood M. Ghani, Douglas A. Dale
  • Patent number: 6596525
    Abstract: The present invention relates to a novel improved protein mutant which produces low allergenic response in humans compared to the parent of that mutant. Specifically, the present invention comprises neutralizing or reducing the ability of T-cells to recognize epitopes and thus prevent sensitization of an individual to the protein.
    Type: Grant
    Filed: February 23, 1999
    Date of Patent: July 22, 2003
    Assignee: Genencor International, Inc.
    Inventors: David A. Estell, Fiona A. Harding
  • Patent number: 6593118
    Abstract: The present invention provides a crystallization process wherein a starting temperature is selected such that a desirable crystal morphology (e.g., square) is obtained. A temperature shift is then introduced, providing that the shift is not enough to induce further nucleation, where the crystals continue to grow in the desirable fashion, but with different kinetics, e.g., a higher rate of crystallization. As a result, the process gives a crystalline product with desirable morphology at a higher crystallization rate.
    Type: Grant
    Filed: November 2, 2001
    Date of Patent: July 15, 2003
    Assignee: Genencor International, Inc.
    Inventor: Meng H. Heng
  • Patent number: 6582750
    Abstract: The present invention relates to variant EGIII cellulases that have improved stability and/or performance. The variant cellulases have replacements at sensitive residues to improve stability and/or performance.
    Type: Grant
    Filed: September 30, 2002
    Date of Patent: June 24, 2003
    Assignee: Genencor International, Inc.
    Inventors: Timothy Fowler, Colin Mitchinson
  • Patent number: 6582914
    Abstract: Methods are disclosed for producing libraries of nucleic acid molecules which libraries are derived from a nucleic acid template. The libraries comprise variant nucleic acids which are produced from a mutagenesis strategy using, e.g., a plurality of defined mutagenic and/or non-mutagenic primers and specific reaction conditions which favor the production of varied combinatorial mutants.
    Type: Grant
    Filed: October 26, 2000
    Date of Patent: June 24, 2003
    Assignee: Genencor International, Inc.
    Inventors: Robert M. Caldwell, Volker Schellenberger
  • Patent number: 6579841
    Abstract: The present invention relates to novel variant EGIII or EGIII-like cellulases which have improved stability. The variant cellulases have performance sensitive residues replaced to a residue having modified stability.
    Type: Grant
    Filed: August 4, 2000
    Date of Patent: June 17, 2003
    Assignee: Genencor International, Inc.
    Inventors: Anthony G. Day, Peter Gualfetti, Colin Mitchinson, Andrew Shaw
  • Patent number: 6565613
    Abstract: A novel textile treatment composition is provided which comprises a builder which does not comprise a significant portion of zeolite. A novel detergent is provided which comprises the following ingredients: (a) 3-25% of water by weight; (b) 20-50% of an alcohol ethoxylate by weight; (c) 5-30% of soda ash by weight; (d) 20-50% of a phosphate type builder by weight; and (e) an alkaline cellulase. The detergent provides optimum conditions for the activity of the alkaline cellulase on the fabrics in the laundry.
    Type: Grant
    Filed: April 29, 1999
    Date of Patent: May 20, 2003
    Assignee: Genencor International, Inc.
    Inventor: Deborah Winetzky
  • Patent number: 6566112
    Abstract: A novel cellulase composition is provided which is predicable by an Actinomycete. The cellulase has an approximate calculated molecular weight of 36 kD and has a pH optimum at 40° C. of 8 and at 60° C. of 7. Also provided is a DNA encoding said cellulase, a method for producing the cellulase and applications thereof.
    Type: Grant
    Filed: February 27, 2001
    Date of Patent: May 20, 2003
    Assignee: Genencor International, Inc.
    Inventors: Brian E. Jones, Wilhelmus A. H. Van Der Kleij, Piet Van Solingen, Walter Weyler
  • Patent number: 6562605
    Abstract: A method is provided for the extraction of water soluble biomaterials such as enzymes or proteins into carbon dioxide utilizing certain carbon dioxide soluble surfactants. The extraction can be performed on an aqueous solution, a fermentation broth or a fluid. The method includes the process steps of forming a carbon dioxide/surfactant mixture which involves dissolving carbon dioxide soluble surfactant(s) in carbon dioxide. The carbon dioxide can be in a liquid or supercritical form and the surfactant includes tail and head groups that interact with the biomaterials. Further, the mixture is added to the aqueous solution, fermentation broth or liquid under conditions to allow for extraction of the biomaterials. The method further includes depressurizing and/or temperature adjusting to remove the water soluble biomaterials. The surfactants include fluroethers, oligomers of propylene-oxide, siloxanes, etc. The biomaterials include proteins or enzymes. The carbon dioxide is suberitical or supercritical.
    Type: Grant
    Filed: November 12, 1996
    Date of Patent: May 13, 2003
    Assignees: Genencor International, Inc., University of Pittsburgh
    Inventors: Eric J. Beckman, Eliador J. Ghenciu, Nathaniel T. Becker, Landon M. Steele
  • Patent number: 6562340
    Abstract: The use is provided of a composition as a feed additive which comprises one or more endoglucanases, and 0-20% by weight, based upon the content of cellulase proteins in the composition, of a cellobiohydrolase. The endoglycanases may be one or more of EGI, EGII EGIII and any functionally active derivative of any thereof. Such endoglucanases may be obtained from a genetically modified strain of the fungus Trichoderma. Also provided is an enzyme-based feed additive which comprises EGI and/or EGII which lack the cellulose binding domain, and 0-20% by weight, based upon the content of cellulase proteins in the additive, of a cellobiohydrolase. A further enzyme-based feed additive is provided which comprises a cereal-based carrier, one or more endoglucanases, and 0-20% by weight, based upon the content of cellulase proteins in the additive, of a cellobiohydrolase. Such enzyme-based feed additives can be incorporated into a cereal-based feed which includes one or more of barley, wheat, tricale, rye and maize.
    Type: Grant
    Filed: August 16, 1995
    Date of Patent: May 13, 2003
    Assignee: Genencor International, Inc.
    Inventors: Michael R. Bedford, Andrew J. Morgan, Timothy Fowler, Kathleen A. Clarkson, Michael Ward, Katherine D. Collier, Edmund A Larenas
  • Patent number: 6562612
    Abstract: A novel cellulase composition is provided which is produced by an Actinomycete. The cellulase has an approximate calculated molecular weight of 36 kD and has a pH optimum at 40° C. of 8 and at 60° C. of 7. Also provided is a DNA encoding said cellulase, a method for producing the cellulase and applications thereof.
    Type: Grant
    Filed: December 18, 2000
    Date of Patent: May 13, 2003
    Assignee: Genencor International, Inc.
    Inventors: Brian E. Jones, Wilhelmus A. H. Van Der Kleij, Piet Van Solingen, Walter Weyler, Frits Goedegebuur
  • Patent number: 6555335
    Abstract: The present invention is directed to novel xylanases (referred to as XYL-IV) and to nucleic acid molecules encoding those xylanases. Also provided herein are vectors and host cells including those nucleic acid sequences, antibodies which bind to the xylanases of the present invention, methods for producing the xylanases of the present invention, and methods employing the xylanases of the present invention.
    Type: Grant
    Filed: September 11, 2000
    Date of Patent: April 29, 2003
    Assignee: Genencor International, Inc.
    Inventors: Markku La Saloheimo, Matti Siika-Aho, Maija Tenkanen, Merja E. Penttila
  • Patent number: 6544792
    Abstract: Described herein are methods and compositions for the production and secretion of polypeptides. Included herein is the use of interrupting peptide transport activity for an increase in polypeptide production and/or secretion.
    Type: Grant
    Filed: June 14, 2000
    Date of Patent: April 8, 2003
    Assignee: Genencor International, Inc.
    Inventor: Maria R. Diaz-Torres
  • Patent number: 6534292
    Abstract: Described herein are methods for generating recombined nucleic acids. In one method, fragments of a sequence are provided wherein the fragments have non-extendable 3′ ends. A primer is provided and the primer and fragments are reacted under conditions to extend the primer to form a recombined nucleic acid molecule. In the methods herein, the non-extendable fragments act only as templates, rather than as templates and primers.
    Type: Grant
    Filed: May 8, 2000
    Date of Patent: March 18, 2003
    Assignee: Genencor International, Inc.
    Inventor: Alexander Volkov
  • Patent number: 6534466
    Abstract: The present invention provides low-density compositions, as well as particulates formed, at least in part, from such compositions. Preferred low-density materials include, for example, hollowspheres, low-density minerals, and low-density wood materials (e.g., sawdust). The low-density compositions of the invention can be formed as particulates, or cores, suitable for use in forming enzyme granules, e.g., marums, layered granules, prills, drum granules, agglomerated granules, or the like. Granules are disclosed having advantageous properties, e.g., low dusting, storage stable, fast enzyme-release profile, low true density, etc. The granules of the invention are especially useful, for example, in liquid detergents and cleaners, such as predominantly aqueous, liquid laundry detergents. In one embodiment, granules are provided having a true, or volumetric, density within a range of from about 0.95 to about 1.4 g/cm3.
    Type: Grant
    Filed: January 7, 2000
    Date of Patent: March 18, 2003
    Assignee: Genencor International, Inc.
    Inventor: Robert I. Christensen, Jr.
  • Patent number: 6521421
    Abstract: The present invention relates to nucleic acid sequences and amino acid sequence for Bacillus subtills disulfide bond isomerases, Dsb1 and Dsb2 and methods for increasing the secretion of heterologous and homologous proteins in gram-positive microorganisms.
    Type: Grant
    Filed: March 22, 2000
    Date of Patent: February 18, 2003
    Assignee: Genencor International, Inc.
    Inventors: Wilhelmus J. Quax, Robert M. Caldwell
  • Patent number: 6521440
    Abstract: The present invention relates to the identification of novel metallo-proteases (MP) in Gram-positive microorganisms. The present invention provides the nucleic acid and amino acid sequences for Bacillus MP. The present invention also provides host cells having a mutation or deletion of part or all of the gene encoding MP. The present invention also provides host cells further comprising nucleic acid encoding desired heterologous proteins such as enzymes. The present invention also provides cleaning compositions comprising an MP of the present invention.
    Type: Grant
    Filed: February 22, 2000
    Date of Patent: February 18, 2003
    Assignee: Genencor International, Inc.
    Inventor: David A. Estell
  • Patent number: 6509171
    Abstract: This invention relates to novel mutant filamentous fungi which are deficient in the gene for the corresponding aspartic proteinase. These organisms are useful production hosts in the production of heterologous polypeptides such as chymosin.
    Type: Grant
    Filed: March 26, 1998
    Date of Patent: January 21, 2003
    Assignee: Genencor International, Inc.
    Inventors: Randy M. Berka, Kirk J. Hayenga, Virgil B. Lawlis, Michael Ward
  • Patent number: 6506579
    Abstract: The present invention relates to secretion in Gram-positive microorganisms. The present invention provides the nuclei acid and amino acid sequences for the Bacillus subtilis secretion factor SecG. The present invention also provides means for increasing the secretion of heterologous or homologous proteins in gram-positive microorganisms.
    Type: Grant
    Filed: March 22, 2000
    Date of Patent: January 14, 2003
    Assignee: Genencor International, Inc.
    Inventors: Wilhelmus J. Quax, Robert M. Caldwell
  • Patent number: 6500211
    Abstract: The present invention relates to variant EGIII cellulases that have improved stability and/or performance. The variant cellulases have replacements at sensitive residues to improve stability and/or performance.
    Type: Grant
    Filed: February 13, 2002
    Date of Patent: December 31, 2002
    Assignee: Genencor International, Inc.
    Inventors: Timothy Fowler, Colin Mitchinson